Runx3 drives a CD8+ T cell tissue residency program that is absent in CD4+ T cells

Raíssa Fonseca(The University of Melbourne), Laura K. Mackay(Peter Doherty Institute), Francis R. Carbone(The University of Melbourne), Susan N. Christo(The University of Melbourne), Natasha Zamudio(The University of Melbourne), Scott N. Mueller(Australian Research Council), Luke C. Gandolfo(The University of Melbourne), Keely M. McDonald(The University of Melbourne), Frank A. Buquicchio(Stanford University), Caleb A. Lareau(Broad Institute), Ansuman T. Satpathy(Parker Institute for Cancer Immunotherapy), Ali Zaid(The University of Melbourne), Andreas Obers(The University of Melbourne), Simone L. Park(Peter Doherty Institute), Maximilien Evrard(Agency for Science, Technology and Research), Sarah Sandford(The University of Melbourne), Thomas N. Burn(Children's Hospital of Philadelphia), Nágela Ghabdan Zanluqui(The University of Melbourne), Sapna Devi(The University of Melbourne), Terence P. Speed(The University of Melbourne)
Nature Immunology
July 26, 2022
Cited by 126


Related Papers